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Objectives: Regular physical activity is routinely recommended in children and
adolescents suffering from narcolepsy type 1 (NT1), but controlled studies analyzing its
influence on sleep/wake behavior, metabolic, and anthropometric profile in pediatric NT1
are lacking.
Methods: Fifty consecutive drug-naïve NT1 children and adolescents were assessed
through actigraphic, clinical, and metabolic evaluations. Patients were compared with
respect to their engagement in leisure-time physical activities (LTPA): patients engaged
in LTPA (n = 30) and patients not engaged (No-LTPA, n = 20), respectively.
Results: LTPA patients presented lower BMI, with different BMI categories distribution
and higher HDL cholesterol, when compared with No-LTPA subjects. Increased night-
sleep duration, higher sleep quality, and reduction of nap frequency were documented
through actigraphy in LTPA subjects. Subjective sleepiness, as measured by ESS-CHAD,
was also lower in LTPA subjects while cataplexy frequency proved similar between the
two groups.
Discussion: In pediatric NT1 patients, regular engagement in LTPA is associated
with significant differences on sleepiness, anthropometric and metabolic profile and
objectively assessed sleep/wake behavior. Engagement in LTPA is beneficial and should
be strongly encouraged in pediatric NT1 patients.
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INTRODUCTION
Narcolepsy type 1 (NT1) is a chronic neurological disease characterized by severe sleepiness,
cataplexy and other REM sleep-like episodes intruding into wakefulness (namely hallucinations,
sleep paralysis, automatic behaviors), and disrupted nocturnal sleep (1).
NT1 is caused by loss of hypothalamic hypocretinergic neurons, reflected by low (<110 pg/mL)
hypocretin-1 (or orexin A) levels in cerebrospinal fluid (CSF hctr-1) (2).
Disease onset often occurs in childhood and early adolescence and is most frequently
accompanied by a rapid weight gain, resulting in overweight or obesity (3–6).
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Although the mechanisms leading to weight gain in NT1
have yet to be elucidated (7), its management is of utmost
importance as it represents an additional disease burden,
negatively impacting on children’s psychosocial functioning and
increasing the cardiovascular and metabolic risk (5, 8).
The promotion of regular physical activity is among the most
effective approaches to control weight in overweight children
and adolescents (9). Although never investigated in narcolepsy
patients, engagement in physical activity is associated with
increased sleep duration and higher sleep quality in healthy
subjects and in primary insomnia patients (10, 11).
In this study we analyzed the influence of regular physical
activity on sleep/wake profile, sleepiness, metabolic and




Fifty drug-naïve NT1 patients ≤ 18 years of age (56% males,
age= 12.58± 2.94 years, range 6-17) were included. All patients
presented with excessive daytime sleepiness, video-documented
cataplexy, mean sleep latency ≤ 8min (3.65 ± 3.20min) with
≥ 2 sleep onset REM periods (SOREMPs, mean = 4.56 ±
0.70) at multiple sleep latency test (MSLT), and low CSF hctr-
1 levels (24.83 ± 31.90 pg/mL). All patients carried the HLA
DQB1∗06:02 allele. Data collection and database formation
were approved by the local health trust’s ethics committee
(Comitato Etico Interaziendale Bologna-Imola, CE-BI, Prot.
Num. 17009) and written informed consent was signed by
parents of patients.
Sleep and Napping Behavior Assessment
Nocturnal sleep and diurnal naps were assessed through seven
days of at-home actigraphic monitoring (Micro Motionlogger
Watch, Ambulatory Monitoring Inc.). Devices were placed on
the non-dominant wrist and initialized to collect and store motor
activity in 1-min epochs.
Actigraphy was performed before diagnostic hospitalization,
during the regular school-week. The description of the
actigraphic variables considered for this work is reported in the
Supplementary Material (12).
Participants also filled in a daily sleep diary and indicated
nocturnal rest period and diurnal naps through the event-marker
button.
Abbreviations: NT1, Narcolepsy type 1; LTPA, leisure-time physical/sporting
activities; CSF hctr-1, cerebrospinal fluid hctr-1; ESS-CHAD, Epworth sleepiness
scale for children and adolescents; MSLT, multiple sleep latency test; SOREMPs,
sleep onset REM periods; HLA, human leukocyte antigen; BMI, body mass index;
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein
cholesterol; TIB, time in bed; eTST, estimated total sleep time; eWASO, estimated
wake after sleep onset; SMA, sleep motor activity; DMA, daytime motor activity;
eDTST, daytime estimated total sleep time; e24hTST, sum of all epochs scored as
sleep in both nighttime and daytime periods.
Physical Activity and Cataplexy
Assessment
Participants and their parents underwent a brief interview aimed
to collect information on physical activity and cataplexy.
Regular engagement in leisure-time physical activity (LTPA),
and whether patients performed their habitual physical
activity schedule during the recording week, has been assessed
by questions validated in other studies (namely “Do you
usually undertake physical/sporting activities after school?”
and “During the last seven days, how many times did you
perform physical/sporting activities after school that increase your
heart rate and make you get out of breath some of the time?”
(13, 14). Information on type of activity, frequency (range 1–7
days), and duration were also collected. Cataplexy frequency
and cataplexy occurrence, during or immediately after (within
15min) performing physical/sporting activities, was also assessed
through semi-structured clinical interview (12). Chronotype
was assessed by means of the Italian version of the reduced
Morningness-Eveningness questionnaire for Children and
Adolescents (rMEQ-CA) (15); subjective sleepiness was assessed




Height, weight, and body mass index (BMI) were measured for
each participant by using a portable stadiometer (Harpenden
Portable Stadiometer); BMI percentile was determined in
comparison with the Italian growth percentile scales (17), with
underweight defined as BMI <5th percentile, normal weight
as BMI >5th and <85th percentile, overweight between 85th
and 95th percentile, and obesity as BMI>95th (18). Blood
samples were collected after fasting from midnight and analyzed
for blood glucose, total cholesterol, high-density lipoprotein
cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-
C), and triglycerides.
Statistical Analyses
For statistical purposes, NT1 children and adolescents were
classified either as “LTPAs” (n = 30) if they were engaged in
any type of LTPA for at least 60min twice a week or “No-LTPAs”
(n = 20). Individual information on physical activity schedule is
reported as Supplementary Material (Table S1).
Group differences in demographic, clinical,
anthropometric/metabolic data and actigraphic parameters
were analyzed by means of chi-squared and independent sample
t-test, followed by effect size computation (Cohen’s d). Analyses
were conducted with IBM SPSS Statistics 19 software (SPSS,
Inc. Chicago, Ill); p-value < 0.05 was considered statistically
significant.
RESULTS
Demographics, clinical, anthropometric, and metabolic data are
reported in Table 1. Significant differences were observed in
subjective sleepiness, with LTPAs presenting lower ESS-CHAD
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Mean ± SD Mean ± SD
DEMOGRAPHIC AND CLINICAL DATA
Male/female 17/13 11/9 0.01† ns
Age at NT1 onset, y 9.21 ± 2.93 8.94 ± 3.83 0.28 ns
Age at observation, y 12.16 ± 2.70 13.23 ± 3.23 −1.27 ns
Diagnostic delay, y 2.74 ± 2.77 4.01 ± 2.89 −1.56 ns
ESS-CHAD 13.40 ± 3.02 16.10 ± 3.40 −2.94 0.005
Cataplexy frequency, (%) ≥1/day 60 65 291.5†† ns
<1/day and ≥1/week 23.3 15
<1/week and ≥1/month 3.3 5
<1/month and ≥1/in 3 months 10.0 10
<1/in 3 months and ≥1/in 6 months 3.3 5
Chronotype (m\i\e) 8\20\2 1\15\4 5.03† ns
NEUROPHYSIOLOGICAL AND BIOCHEMICAL DATA
MSLT-sol, min 3.95 ± 3.50 3.21 ± 2.71 0.80 ns
SOREMP, n◦ 4.57 ± 0.63 4.55 ± 0.83 286†† ns





HLA DQB1*0602 positivity 30/30 20/20
ANTHROPOMETRIC AND METABOLIC FEATURES
BMI 22.87 ± 3.88 27.94 ± 8.41 −2.88 0.006
BMI category (underweight\normal\over\obese) 0/16/9/5 1/1/12/6 13.29† <0.005
Glucose, mg/dL 82.93 ± 7.07 80.67 ± 6.36 1.12 ns
Total cholesterol, mg/dL 172.40 ± 29.90 168.40 ± 40.80 0.40 ns
HDL-C, mg/dL 56.03 ± 13.15 48.35 ± 11.03 2.16 <0.05
LDL-C, mg/dL 101.30 ± 26.40 101.40 ± 29.67 −0.01 ns
Triglycerides, mg/dL 88.60 ± 44.41 93.45 ± 43.31 −0.38 ns
NT1-LTPAs, Narcolepsy type 1 subjects regularly engaged in leisure-time physical/sporting activities; NT1-No LTPAs, Narcolepsy type 1 subjects not engaged in leisure-time
physical/sporting activities; ESS-CHAD, Epworth sleepiness scale for children and adolescent; Chronotype (m, morning type; i, intermediate type; e, evening type); MSLT-sol, mean
sleep latency at MSLT; SOREMPs, sleep-onset REM periods at MSLT; CSF hcrt-1, cerebrospinal fluid hypocretin-1; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol;





score than No-LTPAs, but not in objective sleep propensity or
SOREMPs number at the MSLT. No differences were observed in
cataplexy frequency. Significant differences were also observed in
anthropometric/metabolic features, with LTPAs presenting lower
BMI, a different BMI category distribution, and higher HDL
cholesterol level than No-LTPAs.
Actigraphic variables are reported in Table 2. Significant
differences were observed in nocturnal sleep duration and
quality, with LTPAs displaying increased eTST and sleep
efficiency, reduced eWASO and SMA, despite increased
frequency of nocturnal awakenings when compared to No-
LTPAs. Concerning the daytime period, a significant increase
of DMA, reduced eDTST and naps frequency were observed in
LTPAs.
DISCUSSION
This is the first study that investigated anthropometric/metabolic
features and sleep/wake profile with respect to engagement in
physical/sporting activity among pediatric NT1 patients.
Overall, our results highlight a beneficial association
between regular LTPA and several disease-related aspects.
Although we confirmed the over-representation of overweight
and obesity among pediatric NT1 patients (42% of subjects
being overweight and 22% being obese) (4, 5), our results
showed that NT1 subjects regularly engaged in LTPA (60%
of this cohort) presented with overall lower BMI and lower
prevalence of overweight and obesity (30% overweight,
17% obese) compared to No-LTPAs (60% overweight, 30%
obese).
Moreover, regular involvement in LTPA turned out to
be associated with favorable differences in lipid-lipoprotein
profile as LTPAs present with higher levels of HDL-C and
lower levels of triglycerides when compared to No-LTPAs,
although the latter difference did not reach statistical significance.
Although these results are in line with previous studies on
healthy children and adolescents reporting higher HDL-C and
lower triglycerides levels in physically active subjects, further
confirmation is required by means of interventional studies in
NT1 patients (19).
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Bedtime 22 : 56 ± 00 : 56 23 :33 ± 01 : 24 −1.83 ns
Wake time 07 : 21 ± 00 : 46 07 :50 ± 01 : 27 −1.53 ns
Midpoint 03 : 09 ± 00 : 42 03 :42 ± 01 : 16 −1.95 ns
TIB, min 504.44 ± 59.20 494.98 ± 79.88 0.53 ns
NIGHTTIME PERIOD
eTST, min 355.25 ± 57.56 304.41 ± 67.49 2.86 <0.01 0.75
eSleep efficiency, % 70.64 ± 7.92 62.21 ± 13.02 2.85 <0.01 0.65
eWASO, min 135.25 ± 42.94 168.43 ± 70.64 −2.07 <0.05 −0.47
eAwakenings, n◦ 33.43 ± 7.37 28.50 ± 8.06 2.23 <0.05 0.61
eProlonged awakenings, n◦ 8.77 ± 3.46 9.74 ± 3.08 −1.02 ns
SMA, counts 24.25 ± 5.72 36.08 ± 15.22 −3.88 <0.0005 −0.78
eLongest sleep, min 68.34 ± 13.19 63.74 ± 16.39 1.10 ns
DAYTIME PERIOD
DMA, counts 208.42 ± 22.15 190.29 ± 25.24 2.68 0.01 0.72
eDTST, min 59.34 ± 30.07 84.75 ± 29.67 −2.94 0.005 −0.86
eNap, n◦ 6.30 ± 2.15 10.30 ± 3.31 −5.19 <0.0001 −1.21
eNapD, min 54.89 ± 17.98 54.95 ± 26.75 −0.01 ns
e24hTST, min 414.59 ± 65.04 389.16 ± 73.74 1.28 ns
NT1-LTPAs, Narcolepsy type 1 subjects regularly engaged in leisure-time physical/sporting activities; NT1-No LTPAs, Narcolepsy type 1 subjects not engaged in leisure-time
physical/sporting activities; ES, Cohen’s d; TIB, time in bed; eTST, estimated total sleep time; eWASO, estimated wake after sleep onset; SMA, mean activity counts during TIB;
DMA, mean activity counts during daytime; eDTST, estimated total sleep time during daytime; eNap, total number of daytime estimated sleep episodes during the recording period;
eNapD, mean duration of longest estimated sleep episode; e24hTST, sum of all epoch scored as sleep across nocturnal and diurnal period.
Actigraphy objectively documented higher sleep quality
(higher estimated sleep efficiency and lower eWASO and SMA)
and increased sleep duration (higher eTST) in LTPAs compared
to No-LTPAs, without significant differences in TIB and in
the timing of nocturnal rest period, highlighting the positive
association between regular physical activity and nocturnal sleep
quality.
The abovementioned results are in line with results of previous
studies in good sleepers and primary insomnia patients and, for
the first time, these findings extend to patients suffering from
NT1 (11, 20).
Moreover, regular engagement in LTPA was also associated
with a different diurnal behavior, as LTPAs took fewer naps,
spending less time asleep during daytime. Differences in
subjective sleepiness levels properly confirmed the actigraphic
diurnal profile, with LTPAs displaying lower ESS-CHAD score
than No-LTPAs. Engagement in LTPA was not associated with
differences in cataplexy frequency. However, it is of high
interest to highlight that none of the children and adolescents
reported to experience cataplectic attacks during or immediately
after having performed physical activity. This finding could
have important clinical implications, since concerns have been
raised about the potential adverse effect of physical activity
on cataplexy frequency (21). Indeed, in a murine model of
NT1, physical exercise (wheel running) increased the total
amount of wakefulness to the detriment of a negative effect
on cataplexy and authors pointed out the need to optimize
cataplexy control to derive benefit from physical activity
(21, 22).
Our study suffers from the inherent limitations of a cross-
sectional design, in particular it precludes the possibility
of ruling out reverse causation (i.e., children are able to
perform physical/sports activities because they are not
overweight or obese) and calls for further interventional
studies, in pharmacologically untreated and treated patients.
Moreover, food intake was not monitored in the present
study.
Nonetheless, our study showed that regular engagement in
leisure-time physical/sports activity is associated with significant
differences in children’s anthropometric features, sleepiness and
sleep/wake profile and does not seem to trigger cataplexy, thus
providing a first rationale to implement regular physical activity
as a complementary non-pharmacological approach to assist the
management of pediatric NT1 cases.
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